HI homepage

artificial intelligence
Patients support AI for diagnostic imaging but balk at using it in triage decisions

Previous research has shown that resistance to medical AI may be caused by difficulty in understanding both algorithms and human decision-making in healthcare. 

Bayer
Bayer expands into molecular imaging with 2 acquisitions

The company has reached a deal to purchase two investigational imaging agents from Attralus Inc., a Naples, Florida-based biopharmaceutical firm.

istock-1359148358.jpg
MRI technique reduces low-value surgeries for patients with colorectal cancer

Though effective, surgery for colorectal peritoneal metastases is accompanied by a high risk of major morbidity, making the decision to undergo the procedure complex for many patients.  

outsource in-house
Outsourcing may actually be adding to in-house radiologists' workloads

As organizations turn to external services for help, it is becoming increasingly important for leaders to evaluate how this practice impacts patient care and the bottom line. 

Take Care of Maya johns hopkins attorneys seek retrial
Radiology-related errors have cost hospital system over $2M in recent years

A spokesperson for the organization described such errors as “sincerely regrettable,” adding that the mistakes go against their aim “to provide the best and safest care possible for our patients.” 

Medicaid
Medicaid cuts under ‘One Big Beautiful Bill’ could result in over 1 million missed cancer screenings

Over the first two years of implementation, about 7.5 million Medicaid enrollees eligible for cancer screenings will lose coverage, researchers estimate.  

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.